Results 141 to 150 of about 5,468 (167)

Clinical Pharmacokinetics of Cisatracurium Besilate

Clinical Pharmacokinetics, 2012
V D Schmith, David F Kisor
exaly  

Cisatracurium.

2011
openaire   +1 more source

Does ester hydrolysis change the in vitro degradation rate of cisatracurium and atracurium?

British Journal of Anaesthesia, 2002
H Gilly, H G Kress, H G Kress
exaly  

Cisatracurium

2007
openaire   +1 more source

Cisatracurium Besilate

Drugs, 2012
Harriet M Bryson, Diana Faulds, D Faulds   +2 more
exaly  

The pharmacokinetics and pharmacodynamics of cisatracurium in critically ill patients with severe sepsis

British Journal of Clinical Pharmacology, 2012
Peter Kruger, Michael Roberts, Xin Liu   +2 more
exaly  

HPLC determination of cisatracurium besylate and propofol mixtures with LC-MS identification of degradation products

Journal of Pharmaceutical and Biomedical Analysis, 1998
J T Stewart
exaly  

Cisatracurium Besylate

2021
openaire   +2 more sources

A comparison of the infusion pharmacokinetics and pharmacodynamics of cisatracurium, the 1R‐ cis 1′R‐ cis isomer of atracurium, with atracurium besylate in healthy patients

Anaesthesia, 1997
C J Parker
exaly  

Weal and flare responses to intradermal rocuronium and cisatracurium in humans

British Journal of Anaesthesia, 2000
, F Szlam, J H Levy
exaly